Doctor Tianshu Gu
2nd Hospital of Tianjin Medical University, Tianjin (China)
The impact of pre-myocardial infarction exercise frequency on prognosis in Non-ST segment elevation myocardial infarction patients
Event: ESC Congress 2024
Topic: Non-ST-Elevation Myocardial Infarction (NSTEMI)
Session: Acute and chronic coronary syndromes
Antiplatelet can improve the short-term prognosis of type 2 myocardial infarction caused by acute respiratory failure
Event: ESC Congress 2024
Topic: Pharmacotherapy
Session: Data-driven decisions for anticoagulant and antiplatelet therapy
Both fibrosis-4 index and fibrosis-5 index can predict the prognosis of patients after percutaneous coronary intervention
Event: ESC Congress 2024
Topic: Outcome
Session: All things percutaneous coronary intervention: a potpourri of percutaneous coronary intervention-related topics
Ticagrelor vs. clopidogrel in ST elevation myocardial infarction patients with hemoglobin > 160
Event: ESC Congress 2024
Topic: ST-Elevation Myocardial Infarction (STEMI)
Session: Bleeding and antiplatelet strategies in acute coronary syndromes
Levosimendan improves the early prognosis of patients with Non ST-segment elevation myocardial infarction and Killip class > II
Event: ESC Congress 2024
Topic: Pharmacotherapy
Session: Pharmacotherapy in coronary artery disease: from bench to bedside (2)
The impact of pre-myocardial infarction exercise frequency on prognosis in acute myocardial infarction patients
Event: ESC Congress 2024
Topic: Exercise
Session: Lifestyle, obesity, and dyslipidaemia
